Status:
COMPLETED
Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Nausea and Vomiting
Unspecified Childhood Solid Tumor, Protocol Specific
Eligibility:
All Genders
2-21 years
Phase:
NA
Brief Summary
RATIONALE: Using acupressure wrist bands to press and stimulate nerves at an acupressure point on the inside of the wrist may help control nausea and vomiting caused by chemotherapy. PURPOSE: This ra...
Detailed Description
OBJECTIVES: * Determine the feasibility of implementing an acupressure therapy for the prevention of chemotherapy-associated nausea in children with cancer. * Test the hypothesis that acupressure ban...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patients must receive in-patient primary oncology care at least monthly at Brenner Children's Hospital
- Patients may have any type of cancer
- Must be receiving at least 1 of the following chemotherapy agents as an inpatient:
- An alkylating agent (e.g., cisplatin, cyclophosphamide, or ifosfamide)
- An antitumor antibiotic (e.g., doxorubicin, daunomycin, dactinomycin, or mitoxantrone)
- High-dose cytarabine
- PATIENT CHARACTERISTICS:
- Patient's primary caregiver must speak English
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00310063
Start Date
April 1 2005
End Date
May 1 2007
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157-1096